Arteris, Inc. (NASDAQ:AIP) VP Paul L. Alpern Sells 3,326 Shares

Arteris, Inc. (NASDAQ:AIPGet Free Report) VP Paul L. Alpern sold 3,326 shares of the stock in a transaction on Monday, January 6th. The stock was sold at an average price of $12.35, for a total transaction of $41,076.10. Following the completion of the sale, the vice president now owns 61,604 shares in the company, valued at $760,809.40. The trade was a 5.12 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Arteris Price Performance

Shares of AIP opened at $11.25 on Thursday. The stock has a fifty day simple moving average of $9.16 and a two-hundred day simple moving average of $8.13. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. The company has a market capitalization of $451.99 million, a PE ratio of -11.72 and a beta of 1.17. Arteris, Inc. has a 52-week low of $4.83 and a 52-week high of $12.64.

Hedge Funds Weigh In On Arteris

A number of hedge funds have recently modified their holdings of the business. US Bancorp DE purchased a new stake in Arteris in the 3rd quarter valued at about $34,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Arteris during the second quarter valued at about $86,000. Algert Global LLC purchased a new stake in shares of Arteris in the 2nd quarter valued at approximately $115,000. MetLife Investment Management LLC lifted its holdings in shares of Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after acquiring an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new position in shares of Arteris during the 3rd quarter worth approximately $226,000. 64.36% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Rosenblatt Securities reiterated a “buy” rating and issued a $15.00 target price on shares of Arteris in a research note on Wednesday, November 6th.

Read Our Latest Research Report on AIP

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

See Also

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.